Compare Deep Health AI with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 7.89%
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.26
With ROE of 11.6, it has a Expensive valuation with a 1.3 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Gems, Jewellery And Watches
INR 31 Cr (Micro Cap)
5.00
47
4.44%
-0.11
11.59%
1.26
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Nov-07-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Deep Health AI India Ltd is Rated Strong Sell
Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Deep Health AI India Ltd Valuation Shift Signals Price Attractiveness Change
Deep Health AI India Ltd, a micro-cap player in the Gems, Jewellery and Watches sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. Despite a modest price-to-earnings (P/E) ratio of 5.95, the company’s stock performance continues to lag behind broader market indices, raising questions about its price attractiveness relative to peers and historical benchmarks.
Read full news article
Deep Health AI India Ltd is Rated Strong Sell
Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article Announcements 
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On May 04 2026.
04-May-2026 | Source : BSEDeep Health AI India Ltd has informed BSE that at the meeting of the Board of Directors of the Company held today i.e. 04/05/2026 considered and approved Raising of funds through issue of Equity Shares on Rights basis to the existing shareholders in accordance with the provisions of Companies Act 2013
Board Meeting Intimation for Prior Intimation Pursuant To Regulation 29 Of Securities Exchange And Board Of India (LODR) Regulations 2015 For The Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Monday May 04 2026.
28-Apr-2026 | Source : BSEDeep Health AI India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve Raising of funds through issue of Equity Shares on Rights basis to the existing shareholders in accordance with the provisions of Companies Act 2013 and the rules made thereunder the Securities and Exchange Board of India (ICDR) Regulations 2018.
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
14-Apr-2026 | Source : BSEIn compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the Registered Office of the Company has been shifted from 309 3rd Floor V Star Plaza Plot No. 16 Chandavarkar Road Opp. Saraswat Bank Opposite Raj Mahal Hotel Borivali West Maharashtra India 400092 to 506-509 5th Floor Apeksha Plot No. 256 Main Road Hiran Magri Sector 11 Udaipur Rajasthan- 313001. Further the aforesaid shifting of the Registered Office from the jurisdiction of the Registrar of Companies Mumbai (ROC Mumbai) to the Registrar of Companies Jaipur (ROC Jaipur) has been approved by the Ministry of Corporate Affairs pursuant to the issuance of the Certificate of Registration of the Regional Directors Order for change of State dated March 26 2026. A copy of the said certificate dated March 26 2026 along with the amended Memorandum of Association is enclosed herewith for your reference.
Corporate Actions 
No Upcoming Board Meetings
Deep Health AI India Ltd has declared 10% dividend, ex-date: 07 Nov 25
Deep Health AI India Ltd has announced 1:10 stock split, ex-date: 20 Jan 23
No Bonus history available
Deep Health AI India Ltd has announced 2:1 rights issue, ex-date: 29 Aug 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.35%)
Prakash Rikhabchand Solanki (0.01%)
Vicky Rajesh Jhaveri (2.06%)
94.51%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 7,500.00% vs -92.45% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 332.10% vs -31.93% in Sep 2024
Growth in half year ended Sep 2025 is 430.61% vs 372.22% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 393.83% vs -60.49% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 964.15% vs 51.43% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -50.78% vs -66.62% in Mar 2024
YoY Growth in year ended Mar 2025 is 120.00% vs -68.25% in Mar 2024






